Interventional, Randomized, Double-blind, Cross-over, Placebo-controlled Study to Investigate the Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Nalmefene (Primary)
- Indications Alcoholism
- Focus Pharmacodynamics
- Sponsors Lundbeck A/S
- 10 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Oct 2014 Planned End Date changed from 1 Jun 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
- 10 Oct 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.